Hwang E, Choi G, Kim K, Kim M, Lee S, Lee J
Evid Based Complement Alternat Med. 2022; 2022:9095857.
PMID: 35845596
PMC: 9286971.
DOI: 10.1155/2022/9095857.
Martinez-Linares J
Nurs Rep. 2021; 10(1):2-14.
PMID: 34968259
PMC: 8608083.
DOI: 10.3390/nursrep10010002.
Musini V, Tejani A, Bassett K, Puil L, Wright J
Cochrane Database Syst Rev. 2019; 6:CD000028.
PMID: 31167038
PMC: 6550717.
DOI: 10.1002/14651858.CD000028.pub3.
Henrie A, Sather M, Bakhireva L, Nawarskas J, Boardman K, Huang G
Contemp Clin Trials Commun. 2018; 13:100313.
PMID: 30582070
PMC: 6298905.
DOI: 10.1016/j.conctc.2018.100313.
Kramer H, Cooper R
Curr Hypertens Rep. 2018; 20(2):16.
PMID: 29511979
DOI: 10.1007/s11906-018-0806-x.
Pharmacotherapy for hypertension in adults aged 18 to 59 years.
Musini V, Gueyffier F, Puil L, Salzwedel D, Wright J
Cochrane Database Syst Rev. 2017; 8:CD008276.
PMID: 28813123
PMC: 6483466.
DOI: 10.1002/14651858.CD008276.pub2.
The Case for Low Blood Pressure Targets.
Flack J, Nolasco C, Levy P
Am J Hypertens. 2016; 30(1):3-7.
PMID: 27572960
PMC: 5155566.
DOI: 10.1093/ajh/hpw087.
Coronary heart disease risk factors: public impact of initial and later-announced risks.
Frohlich E, Quinlan P
Ochsner J. 2015; 14(4):532-7.
PMID: 25598717
PMC: 4295729.
Factors influencing the decline in stroke mortality: a statement from the American Heart Association/American Stroke Association.
Lackland D, Roccella E, Deutsch A, Fornage M, George M, Howard G
Stroke. 2013; 45(1):315-53.
PMID: 24309587
PMC: 5995123.
DOI: 10.1161/01.str.0000437068.30550.cf.
Lack of correlation between thiazide-induced hyperglycemia and hypokalemia: subgroup analysis of results from the pharmacogenomic evaluation of antihypertensive responses (PEAR) study.
Smith S, Anderson S, Wen S, Gong Y, Turner S, Cooper-DeHoff R
Pharmacotherapy. 2009; 29(10):1157-65.
PMID: 19792989
PMC: 2777624.
DOI: 10.1592/phco.29.10.1157.
Diuretics, hypokalemia, and cardiac arrhythmia: a 20-year controversy.
Papademetriou V
J Clin Hypertens (Greenwich). 2006; 8(2):86-92.
PMID: 16470076
PMC: 8109414.
DOI: 10.1111/j.1524-6175.2005.04722.x.
Prevention of cardiovascular events in elderly people.
Andrawes W, Bussy C, Belmin J
Drugs Aging. 2005; 22(10):859-76.
PMID: 16245959
DOI: 10.2165/00002512-200522100-00005.
Management of hypertensive chronic kidney disease: role of calcium channel blockers.
Toto R
J Clin Hypertens (Greenwich). 2005; 7(4 Suppl 1):15-20.
PMID: 15858398
PMC: 8109449.
DOI: 10.1111/j.1524-6175.2004.4471.x.
Sexual dysfunction in male patients with hypertension: influence of antihypertensive drugs.
Dusing R
Drugs. 2005; 65(6):773-86.
PMID: 15819590
DOI: 10.2165/00003495-200565060-00005.
Hypertension in the elderly.
Pestana M
Int Urol Nephrol. 2002; 33(3):563-9.
PMID: 12230296
DOI: 10.1023/a:1019552602793.
Approaches to meeting the criteria for fixed dose antihypertensive combinations. Focus on metoprolol.
Kendall M
Drugs. 1995; 50(3):454-64.
PMID: 8521768
DOI: 10.2165/00003495-199550030-00004.
Physical activity in older adults. An overview of health benefits.
Pescatello L, Dipietro L
Sports Med. 1993; 15(6):353-64.
PMID: 8341870
DOI: 10.2165/00007256-199315060-00001.
Prognosis in elderly hypertensive patients.
FREIS E
Drugs Aging. 1994; 4(2):87-92.
PMID: 8186543
DOI: 10.2165/00002512-199404020-00001.
Optimising diuretic therapy in elderly patients with hypertension.
Cushman W
Drugs Aging. 1995; 7(2):88-96.
PMID: 7579787
DOI: 10.2165/00002512-199507020-00003.
Treatment of hypertension in the elderly.
Holzgreve H, Middeke M
Drugs. 1993; 46 Suppl 2:24-31.
PMID: 7512477
DOI: 10.2165/00003495-199300462-00006.
